Katharina Kern Selected Research

Pain Management

1/2018

The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katharina Kern Research Topics

Disease

5	Inflammation (Inflammations) 01/2018 - 01/2017
3	Hyperalgesia 01/2018 - 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022
1	Neoplasm Metastasis (Metastasis) 09/2022
1	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2022
1	Tuberous Sclerosis (Bourneville's Disease) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2018
1	Pain (Aches) 01/2018
1	Fever (Fevers) 01/2018

Drug/Important Bio-Agent (IBA)

3	ZymosanIBA 01/2018 - 01/2017
2	LigandsIBA 01/2018 - 01/2018
2	LipidsIBA 01/2018 - 01/2017
1	Biomarkers (Surrogate Marker)IBA 09/2022
1	HomocysteineIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	trans-sodium crocetinate (crocetin)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ProstaglandinsIBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	EpitopesIBA 01/2018
1	CytokinesIBA 01/2018
1	CC ChemokinesIBA 01/2018
1	Freund's AdjuvantIBA 11/2017
1	LeukotrienesIBA 01/2017
1	Ion Channels (Ion Channel)IBA 01/2017

Therapy/Procedure

1	Pain Management 01/2018